組織診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

組織診断の世界市場規模は、2024年の66億4,000万米ドルから2033年には144億8,000万米ドルに成長し、2026～2033年の予測期間中に9.04％の堅調な年間平均成長率（CAGR）を示すと予測されています。

組織診断市場は、がん罹患率の増加と正確でタイムリーな診断ソリューションに対する需要の高まりに牽引され、大きく成長する展望です。医療プロバイダーが早期発見と個別化された治療計画によって患者の転帰を改善しようとする中、先進的な組織診断技術のニーズが急増しています。病理組織学、免疫組織化学、分子診断学における革新は、組織分析の精度と効率を高め、医療専門家が患者の治療に関して十分な情報に基づいた決定を下せるようにしています。デジタル病理学と人工知能の統合はさらに状況を変え、より正確な画像分析と検査室のワークフロー改善を可能にしています。

さらに、個別化医療が重視されるようになり、組織診断市場に影響を与えています。がんの生物学的理解が進むにつれて、様々ながん種に関連する特定のバイオマーカーを同定できる診断検査に対する需要が高まっています。この動向は、治療方針の決定や治療成績の改善に役立つコンパニオン診断の開発を後押ししています。さらに、腫瘍学の研究開発への注目の高まりは、組織診断における技術革新を促進し、診断能力を高める新規アッセイや技術の導入につながっています。

さらに、がん検診と診断の改善を目的とした啓発キャンペーンやイニシアチブの高まりが、組織診断市場の成長に寄与しています。早期発見の重要性を患者が知るようになるにつれ、信頼性が高く利用しやすい診断ソリューションへの需要が高まると予想されます。また、学術機関、研究機関、産業参入企業の協力も組織診断の進歩を後押ししており、新技術が医療従事者や患者の進化するニーズに確実に応えています。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために、綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 組織診断産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 産業動向
• ポーターのファイブフォース分析
• 市場の魅力分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原料分析
  • 原料リスト
  • 原料メーカー一覧
  • 主要原料の価格動向
• 潜在的バイヤーリスト
• マーケティングチャネル
  • 直接マーケティング
  • 間接マーケティング
  • マーケティングチャネル発展動向

第5章 組織診断の世界市場分析：製品別

• 製品別概要
• 製品別過去・予測データ分析
• 消耗品（抗体、キット、試薬、プローブ）
• 機器（スライド染色システム、スキャナー、組織処理システム、その他の機器（自動カバースリッパ、ミクロトーム、包埋システム、パラフィンディスペンサー、スライドラベラー））

第6章 組織診断の世界市場分析：技術別

• 技術別概要
• 技術別過去・予測データ分析
• 免疫組織化学
• in situハイブリダイゼーション
• デジタルパソロジー＆ワークフロー管理
• 特殊染色

第7章 組織診断の世界市場分析：疾患タイプ別

• 疾患タイプ別概要
• 疾患タイプ別過去・予測データ分析
• 乳がん
• 胃がん
• リンパ腫
• 前立腺がん
• 非小細胞肺がん
• その他の疾患タイプ（神経疾患、心血管疾患、免疫疾患、感染症、骨・大腸・甲状腺・子宮頸部・皮膚がん、胆嚢がん、Hbv、エプスタイン・バーウイルス、肝炎、筋ジストロフィー、腎細胞がん、多形肉腫）

第8章 組織診断の世界市場分析：エンドユーザー別

• エンドユーザー別概要
• エンドユーザー別過去・予測データ分析
• 病院
• 研究所
• 製薬会社
• 開発業務受託機関（CRO）
• その他のエンドユーザー（リファレンスラボ、学術ラボ）

第9章 組織診断の世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他の欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他のアジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他のラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別一覧
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他の中東・アフリカ

第10章 組織診断企業の競合情勢

• 組織診断市場競合
• パートナーシップ/提携/合意
• 合併・買収
• 新製品の上市
• その他の開発

第11章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• PHC Holdings Corporation
• Agilent Technologies Inc.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• GE Healthcare
• Cell Signaling Technology Inc.
• BioGenex
• Siemens

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Consumables (Antibodies, Kits, Reagents, Probes) Market Sales By Geography (USD MN)
• Instruments(Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Market Sales By Geography (USD MN)
• Analysis By Technology (USD MN)
• Immunohistochemistry Market Sales By Geography (USD MN)
• In Situ Hybridization Market Sales By Geography (USD MN)
• Digital Pathology & Workflow Management Market Sales By Geography (USD MN)
• Special Staining Market Sales By Geography (USD MN)
• Analysis By Disease Type (USD MN)
• Breast Cancer Market Sales By Geography (USD MN)
• Gastric Cancer Market Sales By Geography (USD MN)
• Lymphoma Market Sales By Geography (USD MN)
• Prostate Cancer Market Sales By Geography (USD MN)
• Non-small Cell Lung Cancer Market Sales By Geography (USD MN)
• Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Research Laboratories Market Sales By Geography (USD MN)
• Pharmaceutical Companies Market Sales By Geography (USD MN)
• Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
• Other End Users (Reference Laboratories And Academic Research Laboratories) Market Sales By Geography (USD MN)
• Global Tissue Diagnostics Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Tissue Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Tissue Diagnostics Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Technology
• Market Attractiveness Analysis By Disease Type
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Consumables (Antibodies, Kits, Reagents, Probes) Market Sales By Geography (USD MN)
• Instruments(Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Market Sales By Geography (USD MN)
• Global Market Analysis By Technology (USD MN)
• Immunohistochemistry Market Sales By Geography (USD MN)
• In Situ Hybridization Market Sales By Geography (USD MN)
• Digital Pathology & Workflow Management Market Sales By Geography (USD MN)
• Special Staining Market Sales By Geography (USD MN)
• Global Market Analysis By Disease Type (USD MN)
• Breast Cancer Market Sales By Geography (USD MN)
• Gastric Cancer Market Sales By Geography (USD MN)
• Lymphoma Market Sales By Geography (USD MN)
• Prostate Cancer Market Sales By Geography (USD MN)
• Non-small Cell Lung Cancer Market Sales By Geography (USD MN)
• Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Research Laboratories Market Sales By Geography (USD MN)
• Pharmaceutical Companies Market Sales By Geography (USD MN)
• Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
• Other End Users (Reference Laboratories And Academic Research Laboratories) Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Global Tissue Diagnostics Market size is anticipated to grow from USD 6.64 Billion in 2024 to USD 14.48 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.04% during the forecast period of 2026 to 2033.

The tissue diagnostics market is poised for significant growth, driven by the increasing prevalence of cancer and the rising demand for accurate and timely diagnostic solutions. As healthcare providers seek to improve patient outcomes through early detection and personalized treatment plans, the need for advanced tissue diagnostic technologies is surging. Innovations in histopathology, immunohistochemistry, and molecular diagnostics are enhancing the accuracy and efficiency of tissue analysis, enabling healthcare professionals to make informed decisions regarding patient care. The integration of digital pathology and artificial intelligence is further transforming the landscape, allowing for more precise image analysis and improved workflow in laboratories.

Moreover, the growing emphasis on personalized medicine is influencing the tissue diagnostics market. As the understanding of cancer biology advances, there is a rising demand for diagnostic tests that can identify specific biomarkers associated with different cancer types. This trend is driving the development of companion diagnostics that guide treatment decisions and improve therapeutic outcomes. Additionally, the increasing focus on research and development in oncology is fostering innovation in tissue diagnostics, leading to the introduction of novel assays and technologies that enhance diagnostic capabilities.

Furthermore, the rise of awareness campaigns and initiatives aimed at improving cancer screening and diagnosis is contributing to the growth of the tissue diagnostics market. As patients become more informed about the importance of early detection, the demand for reliable and accessible diagnostic solutions is expected to rise. Collaborations between academic institutions, research organizations, and industry players are also driving advancements in tissue diagnostics, ensuring that new technologies meet the evolving needs of healthcare providers and patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

• Consumables
• Antibodies
• Kits
• Reagents
• Probes
• Instruments
• Slide-staining Systems
• Scanners
• Tissue-processing Systems
• Other Instruments (automated cover slippers, microtomes, embedding systems, paraffin dispensers, and slide labelers)

By Technology

• Immunohistochemistry
• In Situ Hybridization
• Digital Pathology & Workflow Management
• Special Staining

By Disease Type

• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Cancer
• Other Disease Types (neurological disease, cardiovascular disease, immunological diseases, infectious diseases, cancers of the bone, colon, thyroid, cervix, and skin; gallbladder carcinoma; HBV; Epstein-Barr virus; hepatitis; muscular dystrophy; renal cell carcinoma; and pleomorphic sarcomas.)

By End User

• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users (reference laboratories and academic research laboratories)
• COMPANIES PROFILED
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• PHC Holdings Corporation
• Agilent Technologies Inc.
• Thermo Fisher Scientific Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. TISSUE DIAGNOSTICS INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Disease Type
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Consumables (Antibodies, Kits, Reagents, Probes) Historic and Forecast Sales By Regions
• 5.4. Instruments(Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Historic and Forecast Sales By Regions

6. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

• 6.1. Overview By Technology
• 6.2. Historical and Forecast Data Analysis By Technology
• 6.3. Immunohistochemistry Historic and Forecast Sales By Regions
• 6.4. In Situ Hybridization Historic and Forecast Sales By Regions
• 6.5. Digital Pathology & Workflow Management Historic and Forecast Sales By Regions
• 6.6. Special Staining Historic and Forecast Sales By Regions

7. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY DISEASE TYPE

• 7.1. Overview By Disease Type
• 7.2. Historical and Forecast Data Analysis By Disease Type
• 7.3. Breast Cancer Historic and Forecast Sales By Regions
• 7.4. Gastric Cancer Historic and Forecast Sales By Regions
• 7.5. Lymphoma Historic and Forecast Sales By Regions
• 7.6. Prostate Cancer Historic and Forecast Sales By Regions
• 7.7. Non-small Cell Lung Cancer Historic and Forecast Sales By Regions
• 7.8. Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Historic and Forecast Sales By Regions

8. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY END USER

• 8.1. Overview By End User
• 8.2. Historical and Forecast Data Analysis By End User
• 8.3. Hospitals Historic and Forecast Sales By Regions
• 8.4. Research Laboratories Historic and Forecast Sales By Regions
• 8.5. Pharmaceutical Companies Historic and Forecast Sales By Regions
• 8.6. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
• 8.7. Other End Users (Reference Laboratories And Academic Research Laboratories) Historic and Forecast Sales By Regions

9. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE TISSUE DIAGNOSTICS COMPANIES

• 10.1. Tissue Diagnostics Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF TISSUE DIAGNOSTICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. F. Hoffmann-La Roche Ltd
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Danaher Corporation
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. PHC Holdings Corporation
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Agilent Technologies Inc.
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Thermo Fisher Scientific Inc.
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Abbott Laboratories
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. GE Healthcare
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Cell Signaling Technology Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. BioGenex
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Siemens
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies